Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
— Risk decreased by 17% with increasing calcium intake, rose with alcohol, red and processed meat
Latest in Oncology/Hematology
Phase III data show promising efficacy with manageable toxicity and feasible delivery
ORR of 80% at recommended dose of talquetamab, teclistamab but with high rates of grade 3/4 AEs
Study suggests that driver mutation monitoring could become standard practice, researcher says
News outlets run stories based on 30-year-old case report of accidental cancer transplantation
Study suggests that driver mutation monitoring could become standard practice, researcher says
News outlets run stories based on 30-year-old case report of accidental cancer transplantation
Oncology/Hematology Case Studies
Rare condition can be deadly without early diagnosis and treatment
Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man
Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge
More in Oncology/Hematology
Treatment tied to higher recovery odds and faster time to kidney recovery
Distant metastases identified in 46% of "negative" cases, including polymetastatic disease in 24%
Study finds TCL1A levels higher in responders, offering insights for improving outcomes
FDA boxed warning led to multiple studies on the issue in 2024
New report emphasizes greater public awareness, education
News, features, and commentary about cancer-related issues
Health news and commentary gathered by MedPage Today staff
Studies show promising EFS, PFS, and OS at 3 to 8 years
Structural elements of private equity ownership linked to higher mortality, complication rates
Novel CD19xCD3 T-cell engager showed high response rate in phase I study
"We should not look at variant allele frequency to make a decision," said Virginia Kaklamani, MD
Lack of control for dietary modification blurred effects of fish oil, experts caution
3-year disease-free survival rate was 96% with blinatumomab versus 87.9% with chemo alone
Greater area deprivation linked to worse progression-free and overall survival
